Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 1
1981 1
1982 2
1984 2
1985 4
1987 1
1988 1
1991 1
1992 2
1994 1
1995 2
1996 7
1997 6
1998 4
1999 12
2000 15
2001 9
2002 6
2003 12
2004 12
2005 18
2006 15
2007 15
2008 18
2009 22
2010 25
2011 44
2012 30
2013 35
2014 45
2015 59
2016 48
2017 43
2018 65
2019 74
2020 103
2021 99
2022 103
2023 92
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

989 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure.
Modzelewski KL, Pipilas A, Bosch NA. Modzelewski KL, et al. JAMA Netw Open. 2024 May 1;7(5):e249305. doi: 10.1001/jamanetworkopen.2024.9305. JAMA Netw Open. 2024. PMID: 38696170 Free PMC article.
OBJECTIVE: To determine the comparative outcomes of empagliflozin and dapagliflozin on reducing the composite of all-cause mortality and hospitalizations in patients with heart failure. DESIGN, SETTING, AND PARTICIPANTS: This multicenter retrospective cohort …
OBJECTIVE: To determine the comparative outcomes of empagliflozin and dapagliflozin on reducing the composite of all-cause mortality and hos …
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, Ahmed FZ, Al-Mohammad A, Cowburn PJ, Foley PWX, Graham FJ, Japp AG, Lane RE, Lang NN, Ludman AJ, Macdougall IC, Pellicori P, Ray R, Robertson M, Seed A, Ford I; IRONMAN Study Group. Kalra PR, et al. Lancet. 2022 Dec 17;400(10369):2199-2209. doi: 10.1016/S0140-6736(22)02083-9. Epub 2022 Nov 5. Lancet. 2022. PMID: 36347265 Free article. Clinical Trial.
BACKGROUND: For patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenous ferric carboxymaltose administration improves quality of life and exercise capacity in the short-term and reduces hospital admissions for …
BACKGROUND: For patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenou …
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Tromp J, Borleffs CJW, Ma C, Comin-Colet J, Fu M, Janssens SP, Kiss RG, Mentz RJ, Sakata Y, Schirmer H, Schou M, Schulze PC, Spinarova L, Volterrani M, Wranicz JK, Zeymer U, Zieroth S, Brueckmann M, Blatchford JP, Salsali A, Ponikowski P. Voors AA, et al. Nat Med. 2022 Mar;28(3):568-574. doi: 10.1038/s41591-021-01659-1. Epub 2022 Feb 28. Nat Med. 2022. PMID: 35228754 Free PMC article. Clinical Trial.
The sodium-glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitalization in patients with chronic heart failure, but whether empagliflozin also improves clinical outcomes when initia …
The sodium-glucose cotransporter 2 inhibitor empagliflozin reduces the risk of cardiovascular death or heart failure hospitali …
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management.
Gevaert AB, Kataria R, Zannad F, Sauer AJ, Damman K, Sharma K, Shah SJ, Van Spall HGC. Gevaert AB, et al. Heart. 2022 Aug 11;108(17):1342-1350. doi: 10.1136/heartjnl-2021-319605. Heart. 2022. PMID: 35022210 Review.
It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection fraction (HFpEF). Yet this form of HF remains a diagnostic and therapeutic challenge. ...This narrative review summarises the pathophysiology, diagnosis, …
It is estimated that half of all patients with heart failure (HF) have HF with preserved ejection fraction (HFpEF). Yet …
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Butler J, Shah SJ, Petrie MC, Borlaug BA, Abildstrøm SZ, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Verma S, Einfeldt MN, Lindegaard ML, Rasmussen S, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Kosiborod MN; STEP-HFpEF Trial Committees and Investigators. Butler J, et al. Lancet. 2024 Apr 27;403(10437):1635-1648. doi: 10.1016/S0140-6736(24)00469-0. Epub 2024 Apr 7. Lancet. 2024. PMID: 38599221 Free PMC article. Clinical Trial.
In both trials, eligible participants were aged 18 years or older, had heart failure with a left ventricular ejection fraction of at least 45%, a BMI of at least 30 kg/m(2), New York Heart Association class II-IV symptoms, and a Kansas City Cardiomyopathy Que …
In both trials, eligible participants were aged 18 years or older, had heart failure with a left ventricular ejection fraction …
Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF).
Schulze PC, Bogoviku J, Westphal J, Aftanski P, Haertel F, Grund S, von Haehling S, Schumacher U, Möbius-Winkler S, Busch M. Schulze PC, et al. Circulation. 2022 Jul 26;146(4):289-298. doi: 10.1161/CIRCULATIONAHA.122.059038. Epub 2022 Jun 29. Circulation. 2022. PMID: 35766022 Free article. Clinical Trial.
BACKGROUND: Effective diuretic regimens using loop diuretics in patients with acute decompensated heart failure are often limited by the development of worsening kidney function. Sodium-glucose cotransporter-2 inhibitors induce glucosuria and sodium excretion …
BACKGROUND: Effective diuretic regimens using loop diuretics in patients with acute decompensated heart failure are oft …
Screening and Initiating Supportive Care in Patients With Heart Failure.
Nguyen Q, Wang K, Nikhanj A, Chen-Song D, DeKock I, Ezekowitz J, Mirhosseini M, Cujec B, Oudit GY. Nguyen Q, et al. Front Cardiovasc Med. 2019 Oct 22;6:151. doi: 10.3389/fcvm.2019.00151. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31696120 Free PMC article.
Background: Patients with heart failure (HF) experience a major symptom burden and an overall reduction of quality of life. However, supportive care (SC) remains an under-utilized resource for these patients. Among the many existing barri …
Background: Patients with heart failure (HF) experience a major symptom burden and an overall reduction of quality of l …
Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
Hersberger L, Dietz A, Bürgler H, Bargetzi A, Bargetzi L, Kägi-Braun N, Tribolet P, Gomes F, Hoess C, Pavlicek V, Bilz S, Sigrist S, Brändle M, Henzen C, Thomann R, Rutishauser J, Aujesky D, Rodondi N, Donzé J, Stanga Z, Mueller B, Schuetz P. Hersberger L, et al. J Am Coll Cardiol. 2021 May 11;77(18):2307-2319. doi: 10.1016/j.jacc.2021.03.232. J Am Coll Cardiol. 2021. PMID: 33958128 Free article. Clinical Trial.
OBJECTIVES: The purpose of this trial was to study the effect of nutritional support on mortality in patients hospitalized with chronic heart failure who are at nutritional risk. METHODS: A total of 645 patients with chronic heart fail …
OBJECTIVES: The purpose of this trial was to study the effect of nutritional support on mortality in patients hospitalized wit …
Digoxin and Mortality in Patients With Atrial Fibrillation.
Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators. Lopes RD, et al. J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060. J Am Coll Cardiol. 2018. PMID: 29519345 Free article. Clinical Trial.
BACKGROUND: Digoxin is widely used in patients with atrial fibrillation (AF). OBJECTIVES: The goal of this paper was to explore whether digoxin use was independently associated with increased mortality in patients with AF and if the association was modified by he …
BACKGROUND: Digoxin is widely used in patients with atrial fibrillation (AF). OBJECTIVES: The goal of this paper was to explore wheth …
Diagnostic Accuracy of Point-of-Care Lung Ultrasonography and Chest Radiography in Adults With Symptoms Suggestive of Acute Decompensated Heart Failure: A Systematic Review and Meta-analysis.
Maw AM, Hassanin A, Ho PM, McInnes MDF, Moss A, Juarez-Colunga E, Soni NJ, Miglioranza MH, Platz E, DeSanto K, Sertich AP, Salame G, Daugherty SL. Maw AM, et al. JAMA Netw Open. 2019 Mar 1;2(3):e190703. doi: 10.1001/jamanetworkopen.2019.0703. JAMA Netw Open. 2019. PMID: 30874784 Free PMC article.
IMPORTANCE: Standard tools used to diagnose pulmonary edema in acute decompensated heart failure (ADHF), including chest radiography (CXR), lack adequate sensitivity, which may delay appropriate diagnosis and treatment. ...RESULTS: The literature search yield …
IMPORTANCE: Standard tools used to diagnose pulmonary edema in acute decompensated heart failure (ADHF), including chest radio …
989 results